- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05665621
The Effects of Strength and Balance Training on Physical Function in Overweight Children
The Effect of Strength and Combined Balance Training Intervention Programme on Physical Function, Physical Activity, and Musculoskeletal Health in Children With Overweight and Obesity
This intervention study aims to examine the efficacy of a school-based exercise programme to improve strength and balance in overweight and obese 7-11-year-olds in the United Kingdom. The main question[s] it aims to answer are:
- Is the school-based exercise programme effective in improving lower limb muscular strength and balance control?
- How do increases in strength and balance skills impact physical function, the risk to musculoskeletal health, and physical activity? Participants will attend baseline, post-intervention, and follow-up testing that includes assessment of strength, balance, 3D gait, plantar pressure, physical function and physical activity. The intervention group will take part in physical activity sessions in their school for 1 hour twice a week for a total of 8 weeks.
Researchers will compare the intervention group to a control group that will take part in no-activity sessions and carry out their normal school and seasonal activities.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Megan Le Warne, MRes
- Phone Number: 020 8240 4034
- Email: megan.lewarne@stmarys.ac.uk
Study Locations
-
-
Greater London
-
Hounslow, Greater London, United Kingdom, TW4 5JW
- Recruiting
- Orchard Primary school
-
Isleworth, Greater London, United Kingdom, TW7 6AB
- Recruiting
- Isleworth Town Primary School
-
-
London
-
Hounslow, London, United Kingdom, TW4 6HR
- Recruiting
- Beavers Primary School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Overweight or obese
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
No intervention, normal activities.
|
|
|
Experimental: Training group
Eight-week in-school strength and balance training program
|
Training program consisting of two 1-hour strength and balance training sessions per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Body Mass Index Z-Score
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Body mass index will be calculated as body mass (kg) / height (m)2.
Body mass will be measured using weighing scales and height by stadiometer whilst participants are barefooted with simple clothing (shorts and t-shirt).
Z-scores denote the standard deviations that BMI for gender and height are from the mean of United Kingdom child reference curves.
A higher z-score means greater BMI than the mean for child gender and height.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in body fat percentage
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Bioelectrical impedance will be used to determine whole-body impedance.
Population-specific equations will be applied to estimate body fat (kg).
The percentage of body fat will be calculated as (Fat Mass (kg)/Body Mass(kg))*100.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in fat free mass (kg)
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Bioelectrical impedance will be used to determine whole-body impedance.
Population-specific equations will be applied to estimate body fat (kg).
Fat-free mass will be calculated as Body Mass (kg) - fat mass (kg).
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in lower limb 3D gait.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Joint angles, moments, and power waveforms of hip, knee and ankle in three dimensions during the stance phase of self-paced walking.
Change in lower limb 3D gait will be determined via a previously validated marker set for obese children, time normalised to 100% of stance phase, and moment and power will be dimensionless normalised to body mass and leg length.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in 3D foot in gait.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
The angle of the forefoot, midfoot, rearfoot and shank in three dimensions during the stance phase of self-paced walking.
Change in foot 3D gait will be determined via a previously validated marker set for obese children, and time normalised to 100% of the stance phase.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in lower limb muscular strength relative to body mass.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Isokinetic dynamometry will be used to determine the maximal strength of hip extension, hip flexion, hip adduction, hip abduction, knee extension, knee flexion, ankle plantarflexion, and ankle dorsiflexion.
Maximal moments will be allometrically scaled to body mass.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in lower limb muscular strength relative to fat free mass.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Isokinetic dynamometry will be used to determine the maximal strength of hip extension, hip flexion, hip adduction, hip abduction, knee extension, knee flexion, ankle plantarflexion, and ankle dorsiflexion.
Maximal moments will be allometrically scaled to fat-free mass.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in six minute walk distance.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
The maximal distance walked in six minutes will be recorded in meters.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in sit to stand repetitions
Time Frame: Baseline to end of 8-week intervention and to end of 8-week follow up period.
|
The maximal number of times participants are able to stand up and sit down in one minute.
The stool used will be adjusted so the participant's knee is at 90 degrees when seated, and arms will be placed across the chest.
|
Baseline to end of 8-week intervention and to end of 8-week follow up period.
|
|
Change in timed up and go time
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
The time (seconds) it takes participants to stand from seated (knees 90 degrees), arms across chest, walk 3m turn and go back to seating.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in single leg stance time
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
The maximum amount of time participants are able to maintain stance on their dominant limb with the non-dominant limb flexed 90 degrees and hands held on the waist.
The test is stopped when the non-dominant limb touches the ground, participants move their hands or dominant limb to maintain balance.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in single leg stance time with eye closed
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
The maximum amount of time participants are able to maintain stance on their dominant limb with the non-dominant limb flexed 90 degrees and hands held on the waist and with their eyes closed.
The test is stopped when the non-dominant limb touches the ground, participants move their hands or dominant limb to maintain balance.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in percentage of time spent in sedentary activity.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Tri-axial accelerometry will be used to determine physical activity over three days (including one weekend day).
Child-specific cutoff equations will be used to determine times of sedentary behaviour.
Total time in mins will be divided by total wear time to get percentage of time in sedentary activity.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in percentage of time spent in moderate to vigorous activity.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Tri-axial accelerometry will be used to determine physical activity over three days (including one weekend day).
Child-specific cutoff equations will be used to determine times spent in moderate to vigorous physical activity.
Total time in mins will be divided by total wear time to get the percentage of time in moderate to vigorous activity.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in total vector magnitude counts
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Tri-axial accelerometry will be used to determine physical activity over three days (including one weekend day).
Vector magnitude counts are a total raw measure of movement.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in quality of life score.
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Previously validated Paediatric Quality of Life (PedsQL; physical function section only) will be completed on a 5-point Likert scale and scored.
Items are reversed, scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, 4=0.
If more than 50% of the items in the scale are missing, the scale scores should not be computed; mean score = Sum of the items over the number of items answered.
A higher score denotes a better quality of life whilst a lower score suggests a poorer quality of life.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in pain reported now
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Previously validated paediatric pain questionnaire visual analogue scale for present pain.
10cm (100mm) visual analogue scales from 0 (Not hurting / No discomfort / No pain) to 10 (100) (Hurting a whole lot / Very uncomfortable / Severe pain).
The value will be presented as mm from 0. A higher value means greater pain is present.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in worst pain
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Previously validated paediatric pain questionnaire visual analogue scale for worst pain in last seven days.10cm (100mm) visual analogue scales from 0 (Not hurting / No discomfort / No pain) to 10 (100) (Hurting a whole lot / Very uncomfortable / Severe pain).
The value will be presented as mm from 0. A higher value means greater pain is present.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in physical activity enjoyment scale
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Previously validated 16-item 5-point Likert scale from 1 (I disagree a lot) to 5 (I agree a lot).
Negatively worded sites are reverse scored, and the overall enjoyment for physical activity score is determined by summing all items.
A higher score means greater enjoyment of physical activity.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
|
Change in basic psychological needs in exercise scale score
Time Frame: Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Previously validated 18-item 5-point Likert scale from 1 (I disagree a lot) to 5 (I agree a lot).
An average score for each subdivision of autonomy, competence, relatedness and teacher relatedness is calculated.
A higher score means positive support felt for each subdivision.
|
Baseline to end of the 8-week intervention and to end of 8-week follow-up period.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- StMarysUC7
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.